Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study

Yuzhong Cui(Tianjin Medical University Cancer Institute and Hospital), Baosheng Li(Shandong First Medical University), Lei Feng(Jiangnan University), Feng Du(Central Hospital of Zibo), Xiaoyang Yin(Qingdao University), Wei Huang(Second Affiliated Hospital of Nanchang University)
Clinical & Translational Oncology
April 1, 2022
Cited by 5


Related Papers